高风险的TP53突变预测了头部和部状细胞癌患者的初级治疗反应不佳
Vito Carlo Alberto Caponio1, Khrystyna Zhurakivska1, Marco Mascitti2
1Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Oral diseases
|July 28, 2023
概括
TP53突变可以预测头部和部状细胞癌 (HNSCC) 的治疗结果. 高风险的TP53突变与较低风险的突变不同,与较差的治疗反应有关.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 生物标志物研究 生物标志物研究
背景情况:
- 头部和部状细胞癌 (HNSCC) 对全球健康构成重大挑战,治疗效果有限.
- 由于治疗结果的可变性,对指导HNSCC治疗的预测生物标志物的需求至关重要.
- TP53突变特征已经成为HNSCC的潜在预后因素.
研究的目的:
- 评估TP53突变作为HNSCC治疗结果的预测生物标志物的作用.
- 评估不同TP53突变景观分类系统的实用性.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据库用于临床和基因组数据.
- 采用多变量渐进逆向二进制回归模型来分析TP53突变对治疗结果的影响.
主要成果:
- 与野生型TP53.3相比,高风险TP53突变与3.301的稳定或渐进性疾病概率比率有关.
- 在低风险TP53突变和野生型TP53.3之间没有观察到治疗结果的显著差异.
- 高龄和酒精消费史与稳定/进展性疾病风险增加相关.
结论:
- 这项研究增强了对TP53突变在预测HNSCC治疗反应中的作用的理解.
- TP53突变状态作为HNSCC治疗结果的有价值的预测生物标志物.
相关概念视频
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


